ADT plus TAK-700 with ADT plus bicalutamide in patients with newly diagnosed mHSPC

HCRN GU 16-257: Phase 2 trial of gemcitabine, cisplatin, plus nivolumab with selective bladder sparing in MIBC patients

PEACE-1: Abiraterone acetate plus prednisone and/or local radiotherapy in men with de novo mCSPC

Highlights from ASCO 2021

OncoAlert and ecancer ASCO roundup - Day 3

OncoAlert and ecancer ASCO roundup - Day 1

ASCO 2021: Latest on PARPi and other treatments for mCRPC

Long term outcome of enfortumab vedotin + pembrolizumab in first line locally advanced or metastatic urothelial carcinoma

ASCO 2021: Renal cancer roundup

KEYNOTE-564: Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma

OncoAlert and ecancer weekly roundup for April 26 - May 3, 2021

Healthy lifestyle may offset risk of lethal prostate cancer in men with high genetic risk